UK markets closed
  • FTSE 100

    -88.24 (-1.17%)
  • FTSE 250

    -211.27 (-0.97%)
  • AIM

    -4.13 (-0.38%)

    +0.0012 (+0.10%)

    +0.0019 (+0.14%)

    +505.16 (+1.83%)
  • CMC Crypto 200

    +21.37 (+2.54%)
  • S&P 500

    +105.34 (+2.43%)
  • DOW

    +564.69 (+1.65%)

    +0.68 (+0.79%)

    -2.70 (-0.15%)
  • NIKKEI 225

    +547.04 (+2.09%)

    -256.92 (-1.08%)
  • DAX

    -205.32 (-1.32%)
  • CAC 40

    -57.92 (-0.82%)

Automated Cannabis Testing Market Report Up to 2031: Visiongain Research Inc

·6-min read

Visiongain has published a new report on Automated Cannabis Testing Market Report to 2031. Market is segmented by type (Terpene profiling, Residual Solvents, Heavy Metals, Pesticide Screening, Potency testing, Microbial Testing, Genetic Testing), By Product & Software (Analytical Instruments(Chromatography Instruments, Gas Chromatography, Liquid Chromatography, Others, Spectroscopy Instruments, Mass Spectroscopy, Atomic Spectroscopy, Other), Consumables (Chromatography Column, Supplies and Accessories, Standards and CRMS, Sample Preparation Products), Software), By End User (Testing Laboratories, Research Institute, Others). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Automated Cannabis Testing Companies. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing adoption of laboratory information management system (LIMS) in Cannabis Testing Laboratories and Rising Number of Cannabis Testing Laboratories are some of the factors driving the growth of Automated Cannabis Testing market.

COVID-19 Impact on the Global Automated Cannabis Testing Market
The COVID-19 is a new virulent disease, growing transmission and fatal outcome in the global population. The use of cannabidiol (CBD) in medical purposes is safe & effective to treat medical condition. The CBD has anti-inflammatory properties, and have ability to reduce pain & anxiety. Additionally, the combination of other cannabinoids and terpenes, are significant in clinical intervention, and have potential to treat symptoms of a virus such as COVID-19.

Market Driver
Rising legalization for therapeutic & medical use.

The use of Cannabis for Therapeutic Purposes (CTP) has recently become legal in various countries. However, the legalization in various places enables in easy availability, and change in cannabis perceptions. The increasing clinical evidence-base for use of cannabis therapeutics associated social and political pressures to modify regulatory frameworks for legalization on the use of cannabis. The marijuana plant Cannabis sativa and derivatives, cannabinoids, has significant potential therapy for inflammatory bowel disease (IBD). The Cannabidiol is one of the naturally occurring cannabinoids, which is found in cannabis. The cannabinoids are efficient to treat epilepsy in various clinical trials. The Epidiolex oral solution is one pure CBD product, received US FDA approval treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome.

Increasing adoption of laboratory information management system (LIMS) in Cannabis Testing Laboratories
The Laboratory Information Management System (LIMS) is a software tool enables in efficient data management and laboratory operation. It enables to provide regulatory compliance and offers accurate and speedy outcomes. The cannabis testing workflow provides wide range of testing services which includes terpene profiling, screening pesticide level, heavy metal, and residual solvent testing.

Market Opportunity
Increasing recommendation to encourage improvisation in cannabis research.
The U.S. Department of Health and Human Services, including the National Institutes of Health and the Centers for Disease Control and Prevention, must collaborate to jointly invest in R&D, & ensure the implementation of guidelines for production of high-quality cannabis research. The research programs must enhance the benefits linked with acute & chronic use and reduce harm associated with cannabis & cannabinoids.

Get Detailed TOC @

Competitive Landscape
Agilent Technologies, Inc., Shimadzu Corporation, MCS, Inc., Restek Corporation, A&L Canada Laboratories Inc., Marrone Bio Innovations, Emerald Scientific LLC, PerkinElmer, Inc., Millipore Sigma, AB SCIEX LLC are some of the key players contributing to the growth of the global Automated Cannabis Testing market. The market players are adopting new strategies to stay competitive in the global market such as new product developments, joint ventures, mergers and acquisitions, and geographical expansions.

For instance, in August 2020, A&L Canada Laboratories Inc. announced the addition of Hop Latent Viroid (HLVd) testing to their Cannabis Disease Diagnostics Services. The company is providing Plant Disease Diagnostics (PDD), for horticultural and greenhouse crops. The company offers inclusive pest diagnosis and services to detect plant pathogens such as fungi, bacteria, viruses, and nematodes, associated with plant tissues, soils, composts and water.

  • In October 2020, PerkinElmer, Inc. launched a fully automated liquid handling sample preparation and LC/MS/MS analysis workflow for pesticide residue testing of cannabis and hemp flower samples. It offers cannabis-optimized reagents, sample prep consumables, proprietary cannabis SOPs and cloud-based tracking and reporting software.

  • In August 2020, Marrone Bio Innovations, Inc. an international leader in sustainable bioprotection and plant health solutions, entered in an agreement with Vive Crop Protection. The collaboration enables the company to combine biological with Allosperse Delivery System. The first product to come from this joint effort will The AZterknot FC will be company’s joint product, a fungicide for broad crop use marketed by Vive Crop Protection.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

To access the data contained in this document please email

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Automated Cannabis Testing market and leading companies. You will find data, trends and predictions.

Find more Visiongain research reports on Pharma Diagnostics Sector click on the following links:

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help:

About Visiongain

Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.


Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Follow Us: LinkedIn | Twitter


SOURCE Visiongain Limited.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting